Fig. 2From: Identification of MET fusions as novel therapeutic targets sensitive to MET inhibitors in lung cancerFusion sites and types of MET fusions in selected lung cancer patients. A MET gene structure and exons that participate in the fusion. B Types of MET fusions in lung cancer patients. C Pathological types of patients harboring MET fusionsBack to article page